NFGH
DYN icon

Nan Fung Group Holdings’s Dyne Therapeutics DYN Stock Holding History

Nan Fung Group Holdings’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,629
Closed -$112K – 44
2022
Q1 		$112K Hold
11,629
– – 0.05% 43
2021
Q4 		$138K Hold
11,629
– – 0.04% 53
2021
Q3 		$189K Buy
+11,629
New +$206K 0.06% 27

Other funds holding DYN

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Nan Fung Group Holdings's DYN Position: Q2 2022 in Review

Nan Fung Group Holdings sold out of Dyne Therapeutics (DYN) in Q2 2022, closing a stake of 11,629 shares — an estimated $112K sold.

Nan Fung Group Holdings first reported a position in DYN in Q3 2021 and held it in 3 quarters. The position peaked at $189K in Q3 2021. 90 funds tracked by Wall St. Rank hold DYN as of Q2 2022.

  • Nan Fung Group Holdings reported no remaining Dyne Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 11,629 Dyne Therapeutics shares in Q2 2022, an estimated $112K.
  • Nan Fung Group Holdings first reported a position in Dyne Therapeutics in Q3 2021 and held it in 3 quarters.
  • Nan Fung Group Holdings's Dyne Therapeutics position peaked at $189K in Q3 2021.
  • 90 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2022.

Based on Nan Fung Group Holdings's 13F filing for Q2 2022, filed 12 Aug 2022.